Isabella Presch MD MBA
@isabellapresch.bsky.social
56 followers 99 following 14 posts
Medical Executive | Clinical Research | Medical Affairs | rare diseases | Advanced Therapies | pediatrics
Posts Media Videos Starter Packs
Reposted by Isabella Presch MD MBA
meduniwien.ac.at
🤖🩸 #ArtificialIntelligence in everyday clinical practice: A study by #MedUniVienna shows that language models sometimes provide better answers than experts when it comes to questions about #venousthromboembolism. ⬇️

📰 Results in @jthjournal.bsky.social​​
Artificial intelligence on a par with thrombosis experts
Learn more about the potential and limitations of language models in everyday clinical practice!
www.meduniwien.ac.at
Reposted by Isabella Presch MD MBA
haemnet.bsky.social
Ready for the next #Haemcast? Coming this Thursday, @katekhair.bsky.social looks back on Terence O'Rourke's reflections on life with severe haemophilia and how #haemophilia care has and hasn't changed. https://loom.ly/A4UWu6M
#HemeSky #BloodSky #MedSky #podcast
Reposted by Isabella Presch MD MBA
shematologist.medsky.social
PSA:

Your period should not
🩸last > 7 days
🩸interfere with your life
🩸happen consistently > than monthly
🩸require product changes more than every 2 hours
🩸have clots larger than a quarter
🩸cause debilitating pain
🩸require double product coverage
🩸make you anemic

You don’t have to suffer.
Reposted by Isabella Presch MD MBA
shematologist.medsky.social
Fantastic few days in DC with @ash.hematology.org for media training and the Communications committee meeting.

Fabulous people, incredible food, and inspiring discussions on how we can all continue the important work that’s being done.
ash.hematology.org
ASH Committee on Communications Summer 2025 meeting complete! Energized to strengthen our Fight4Hematology campaign & advocacy efforts protecting federal funding for hematology research. The future of hematology care depends on continued innovation. #ASH #Fight4Hematology
Reposted by Isabella Presch MD MBA
jama.com
JAMA @jama.com · Jul 5
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.

Learn more in this Review.

https://ja.ma/4krNDZU
Figure 1.  Pathophysiology of Immune Thrombotic Thrombocytopenic Purpura
Reposted by Isabella Presch MD MBA
haemnet.bsky.social
Women affected by #haemophilia often experience delayed diagnosis. This means not having access to the treatment & care they need, impacting quality of life and putting them at risk of serious bleeding. Time to bust the myth that #women don't have haemophilia. #womenbleedtoo

#HemeSky #BloodSky
Reposted by Isabella Presch MD MBA
isth.org
📚Spotlight on ISTH publications at #ISTH2025:
@rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
@jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance

Learn more: bit.ly/4k5PbID
Publications Spotlight: JTH & RPTH
ISTH Publications – Research and Practice in Thrombosis and Haemostasis (RPTH) Research and Practice in Thrombosis and Haemostasis (RPTH) is the open-access, online-only journal of the ISTH. Foll...
bit.ly
Reposted by Isabella Presch MD MBA
tomreiser.bsky.social
What an inspiring #ISTH2025!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
Reposted by Isabella Presch MD MBA
middeldorps.bsky.social
Why do we have so little data on pregnancy and thrombotic outcomes in #APS??

Well-illustrated by State-of-the-Art lecture by dr Karen Breen.

We MUST do better!

#ISTH2025
isabellapresch.bsky.social
Last day of another fantastic #ISTH2025 #science #innovation #clinicalresearch #thrombosis #hemostasis
Looking forward to #ISTH2026 in Paris
isabellapresch.bsky.social
Last day starts with an
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?
isabellapresch.bsky.social
Joint Session on VWD & women’s health issues in #thrombosis and #hemostasis Gynecological bleeding and management in women with VWD #ISTH2025 #hematology #gynecology Dr Ozlem Turan, Royal Free Hospital NHS
Reposted by Isabella Presch MD MBA
middeldorps.bsky.social
It’s really worth stopping by our @isth.org booth and get inspired for next year’s meeting in….. Paris!

#ISTH2025
isabellapresch.bsky.social
m-EASIX a feasible tool that may help predict severe CAR T cell toxicities at early stages of immunotherapy #ISTH2025 #CART Poster presented by Dr Ana Belen Moreno-Castano
isabellapresch.bsky.social
Dr Fogerty provides historic and potential future directions for autoantibody testing in #ITP #ISTH2025 #autoantibodytesting
Reposted by Isabella Presch MD MBA
middeldorps.bsky.social
What a fantastic plenary lecture by Prof Jennifer Curnow - in loving and admiring memory of my dear friend Dr Claire McLintock.

#ISTH2025
Reposted by Isabella Presch MD MBA
isth.org
The ISTH Congress Daily News team interviews Bob Montgomery as he prepares to receive the Harold R. Roberts Award today at #ISTH2025. Watch the interview tomorrow at isthcongressdaily.org
isabellapresch.bsky.social
Glenn Pierce: what does the future look like? #genetherapy #hemophilia #toolbox #ISTH2025 Shared and informed decision making is essential
Reposted by Isabella Presch MD MBA
middeldorps.bsky.social
Having fun and enjoying excellent science #ISTH2025 now on to my favourite topic #pregnancy and #thrombosis. Interesting cohort study on #LMWH - with therapeutic dose postpartum - still VTE. I think it could be a problem with adherence even though this was assessed by self-reporting
isabellapresch.bsky.social
Patient advocate perspectives presented by Brian O‘Mahony #ISTH2025 #genetherapy #hemophilia #patientadvocate
Reposted by Isabella Presch MD MBA
ash.hematology.org
The updated #VTE guidelines from ASH and @isth.org‬ provide evidence-based recommendations to support better outcomes for children facing blood clots.

Explore the full guidelines & check out supporting resources: https://bit.ly/3HN5OLN

#HemeSky #MedSky